Mastodawn

Proteinreinigung gescheitert? Forschende testen ein KI-Agenten-System, das automatisch ähnliche Proteine, Literatur, die #PDB und Methoden durchforstet, um Protokolle gezielt zu verbessern. Noch nicht laborgeprüft, aber vielversprechend - Der Artikel von Andrea Pitzschke: https://www.laborjournal.de/editorials/3457.php

#Laborjournal #LifeSciences #Proteinreinigung #KI #Biotech

Formiche.net - Analisi, commenti e scenari 7h ago

Vivere più a lungo non basta. La vera partita è la sostenibilità della longevità

https://web.brid.gy/r/https://formiche.net/2026/03/longevita-sanita-biotech-sostenibilita/

Winbuzzer 7h ago

https://winbuzzer.com/2026/03/19/chatgpt-did-not-cure-dogs-cancer-viral-ai-hype-xcxwbn/

ChatGPT Did Not Cure a Dog's Cancer. Here's What Actually Happened

#AI #ChatGPT #OpenAI #AIMisinformation #Health #MedicalResearch #Science #Biotech #GregBrockman #ElonMusk #xAI #Grok #AlphaFold #GoogleDeepMind #Google #Chatbots #AIEthics

KAPUALabs 15h ago

Obesity drugs are revolutionizing Big Pharma. Eli Lilly $LLY leads with oral GLP-1 technology but faces significant pricing pressure from the Inflation Reduction Act. Our deep dive explores China expansion, manufacturing scale, and competitive moats: https://post.kapualabs.com/2p8kk5u5 #Pharmaceuticals #Biotech #Investing $LLY

KAPUALabs 16h ago

Eli Lilly's obesity drug leadership faces a crucial test with the upcoming orforglipron launch. Our analysis examines whether the $800B valuation can withstand pricing pressures and manufacturing constraints. https://post.kapualabs.com/ye388vvf #PharmaAnalysis #Biotech #Investing $LLY

KAPUALabs 16h ago

The GLP-1 market is expanding rapidly with 2.5M monthly users, but emerging bone health risks & oral formulation challenges create complexity. Our 'Listerian analysis' examines the competitive landscape, safety signals, and strategic implications for $LLY and other pharma players. Dive into the comprehensive review: https://post.kapualabs.com/2p92fdse

#Pharma #Biotech #GLP1 #StockMarket

KAPUALabs 16h ago

$LLY's strategic transformation reveals how manufacturing efficiency and clinical superiority are defining the obesity drug race. Analysis covers small molecule advantages, $9B capacity investment, and digital distribution innovations. Read: https://post.kapualabs.com/29rpnrtp #Biotech #StockMarket #Investing $LLY

KAPUALabs 16h ago

Watching Schumpeterian creative destruction unfold in real-time: Eli Lilly ($LLY) is leveraging clinical and manufacturing advantages to reshape obesity therapeutics after Novo Nordisk's ($NVO) setback. Deep analysis of this market reordering: https://post.kapualabs.com/2hxk48xj #Pharmaceuticals #StockMarket #CreativeDestruction #Biotech

News-Cafe.eu blog 1d ago

Can humans outlive the stars?

https://medium.com/@sensmedia.srl/can-humans-outlive-the-stars-f63d63dd9765
#death #immortality #neuralink #technology #ai #artificialintelligence #biotech #genetics

MoveTheNeedle.news Official 1d ago

Basecamp Research launches the Trillion Gene Atlas — aiming to expand global genetic data 100x and accelerate AI-driven drug discovery.

In collaboration with Anthropic, Ultima Genomics and PacBio, the initiative aims to collect genomic data from more than 100 million species worldwide and compress processes that traditionally take decades into a matter of years.

So what could this mean for the future of medicine?

https://www.movetheneedle.news/technology/basecamp-research-launches-trillion-gene-atlas-to-accelerate-ai-drug-discovery/

#AI #biotech #drugdiscovery #lifesciences #science

Basecamp Research launches Trillion Gene Atlas to accelerate AI drug discovery

Basecamp Research launches the Trillion Gene Atlas to expand global genomic data and accelerate AI-driven drug discovery, signalling a shift towards data-driven medicine.